Clinical Scorecard: Factors Influencing Recurrence Following Vesicovaginal Fistula Repair: A Systematic Review of Surgical and Patient-Related Variables
At a Glance
Category
Detail
Condition
Vesicovaginal Fistula (VVF)
Key Mechanisms
Factors influencing recurrence include fistula size, tissue characteristics, and surgical technique.
Target Population
Females with vesicovaginal fistula, particularly those undergoing surgical repair.
Care Setting
Surgical centers specializing in VVF repair.
Key Highlights
Primary success rates of VVF repair range from 80-95%.
Recurrence rates reported between 10-30%.
Predictors of recurrence include fistula size >2-3cm and severe peri-fistula fibrosis.
Protective factors include early intervention and surgery in specialist centers.
The Goh and Panzi classifications assist in risk stratification.
Guideline-Based Recommendations
Diagnosis
Utilize validated predictive factors for preoperative risk stratification.
Management
Consider surgical intervention in specialist centers for improved outcomes.
Monitoring & Follow-up
Monitor for recurrence based on identified predictors.
Risks
Be aware of the risk factors such as fistula size and previous surgical history.
Patient & Prescribing Data
Females with VVF requiring surgical repair.
Secondary VVF repair may improve surgical outcomes, although results for previously failed repairs are variable.
Clinical Best Practices
Implement early intervention strategies.
Utilize interposition flaps during repair when indicated.
Conduct surgeries in specialized centers to optimize outcomes.
A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.
